TGFB1 and prostate carcinoma: Intriguingly, treatment with TGF-β1 lowered AC activity in cardiomyocytes and prostate cancer cells, which suggests a possible reduction of AC protein expression (Steiner et al., 1994; Nair et al., 1995).